Stem cells offer hope in cerebral palsy battle
from Triangle Business Journal
A Duke University physician believes the key to curing, or at least lessening the severity of, cerebral palsy lies within cord blood stem cells, and she has begun a clinical trial to find out if that is true. Dr. Joanne Kurtzberg, director of Duke’s Pediatric Bone Marrow and Transplant program and director of the Carolinas Cord Blood Bank, has begun a U.S. Food and Drug Administration-authorized random clinical trial to see if cord blood stem cells have the ability to cure or lessen spastic cerebral palsy in children aged 1 to 6. It is among a handful of FDA-authorized clinical trials regarding stem cells in the U.S.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063